EPISODE · Aug 19, 2022 · 14 MIN
MPR Weekly Dose 127 — Novavax Booster; OTC Hearing Aids; Combo Prostate Cancer Tx; First Gene Therapy for Beta-Thalassemia; Repeat At-Home COVID-19 Testing Needed
from MPR Weekly Dose
Novavax vaccine booster update; over-the-counter hearing aids; priority review for a castration-resistant prostate cancer combination treatment; a first gene therapy approved for beta-thalassemia; FDA urges repeat at home COVID-19 testing to reduce risk of missing infection.
Embed this episode
Ready to play
MPR Weekly Dose 127 — Novavax Booster; OTC Hearing Aids; Combo Prostate Cancer Tx; First Gene Therapy for Beta-Thalassemia; Repeat At-Home COVID-19 Testing Needed
0:00
14:50
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MPR Weekly Dose?
This episode is 14 minutes long.
When was this MPR Weekly Dose episode published?
This episode was published on August 19, 2022.
Can I download this MPR Weekly Dose episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!